Literature DB >> 26869204

HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies.

Steven W de Taeye1, John P Moore2, Rogier W Sanders3.   

Abstract

The identification of multiple broadly neutralizing antibodies (bNAbs) against the HIV-1 envelope glycoprotein (Env) trimer has facilitated its structural characterization and guided Env immunogen design. Several recent studies constitute progress in utilizing this knowledge for the development of an HIV-1 vaccine that induces bNAbs. Native-like Env trimers can induce autologous NAb responses against resistant (Tier-2) viruses in several animal models. Here we review recent studies aimed at addressing the challenge of driving the strong but narrowly focused NAb responses to Env trimers towards ones with much greater breadth. Among strategies that merit pursuing are using multiple trimers as sequential or simultaneous immunogens, targeting the germline precursors of bNAbs, delivering sequential lineages of trimers derived from infected individuals who developed bNAbs, and presenting trimers as particulate antigens.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26869204      PMCID: PMC5454186          DOI: 10.1016/j.it.2016.01.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  108 in total

1.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains.

Authors:  Daniela Fera; Aaron G Schmidt; Barton F Haynes; Feng Gao; Hua-Xin Liao; Thomas B Kepler; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

3.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

4.  Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.

Authors:  Jean-Philippe Julien; Jeong Hyun Lee; Albert Cupo; Charles D Murin; Ronald Derking; Simon Hoffenberg; Michael J Caulfield; C Richter King; Andre J Marozsan; Per Johan Klasse; Rogier W Sanders; John P Moore; Ian A Wilson; Andrew B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

5.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

6.  Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

Authors:  Punnee Pitisuttithum; Sorachai Nitayaphan; Prasert Thongcharoen; Chirasak Khamboonruang; Jerome Kim; Mark de Souza; Thippawan Chuenchitra; Robin P Garner; Darawan Thapinta; Victoria Polonis; Silvia Ratto-Kim; Penprapa Chanbancherd; Joseph Chiu; Deborah L Birx; Anne-Marie Duliege; John G McNeil; Arthur E Brown
Journal:  J Infect Dis       Date:  2003-07-03       Impact factor: 5.226

7.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.

Authors:  Rajesh P Ringe; Rogier W Sanders; Anila Yasmeen; Helen J Kim; Jeong Hyun Lee; Albert Cupo; Jacob Korzun; Ronald Derking; Thijs van Montfort; Jean-Philippe Julien; Ian A Wilson; Per Johan Klasse; Andrew B Ward; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

8.  Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.

Authors:  Kwinten Sliepen; Gabriel Ozorowski; Judith A Burger; Thijs van Montfort; Melissa Stunnenberg; Celia LaBranche; David C Montefiori; John P Moore; Andrew B Ward; Rogier W Sanders
Journal:  Retrovirology       Date:  2015-09-26       Impact factor: 4.602

9.  A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.

Authors:  Rogier W Sanders; Ronald Derking; Albert Cupo; Jean-Philippe Julien; Anila Yasmeen; Natalia de Val; Helen J Kim; Claudia Blattner; Alba Torrents de la Peña; Jacob Korzun; Michael Golabek; Kevin de Los Reyes; Thomas J Ketas; Marit J van Gils; C Richter King; Ian A Wilson; Andrew B Ward; P J Klasse; John P Moore
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

10.  Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.

Authors:  Jinal N Bhiman; Colin Anthony; Nicole A Doria-Rose; Owen Karimanzira; Chaim A Schramm; Thandeka Khoza; Dale Kitchin; Gordon Botha; Jason Gorman; Nigel J Garrett; Salim S Abdool Karim; Lawrence Shapiro; Carolyn Williamson; Peter D Kwong; John R Mascola; Lynn Morris; Penny L Moore
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

View more
  64 in total

1.  Dense Array of Spikes on HIV-1 Virion Particles.

Authors:  Armando Stano; Daniel P Leaman; Arthur S Kim; Lei Zhang; Ludovic Autin; Jidnyasa Ingale; Syna K Gift; Jared Truong; Richard T Wyatt; Arthur J Olson; Michael B Zwick
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

Review 2.  How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.

Authors:  Marie Pancera; Anita Changela; Peter D Kwong
Journal:  Curr Opin HIV AIDS       Date:  2017-05       Impact factor: 4.283

3.  Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.

Authors:  Gwo-Yu Chuang; Hui Geng; Marie Pancera; Kai Xu; Cheng Cheng; Priyamvada Acharya; Michael Chambers; Aliaksandr Druz; Yaroslav Tsybovsky; Timothy G Wanninger; Yongping Yang; Nicole A Doria-Rose; Ivelin S Georgiev; Jason Gorman; M Gordon Joyce; Sijy O'Dell; Tongqing Zhou; Adrian B McDermott; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  Optimal immunization cocktails can promote induction of broadly neutralizing Abs against highly mutable pathogens.

Authors:  J Scott Shaffer; Penny L Moore; Mehran Kardar; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

Review 5.  Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Frederick W Alt; Ming Tian
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 6.  Complex immune correlates of protection in HIV-1 vaccine efficacy trials.

Authors:  Georgia D Tomaras; Stanley A Plotkin
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

7.  HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan Metabolism.

Authors:  Todd Bradley; Guang Yang; Olga Ilkayeva; T Matt Holl; Ruijun Zhang; Jinsong Zhang; Sampa Santra; Christopher B Fox; Steve G Reed; Robert Parks; Cindy M Bowman; Hilary Bouton-Verville; Laura L Sutherland; Richard M Scearce; Nathan Vandergrift; Thomas B Kepler; M Anthony Moody; Hua-Xin Liao; S Munir Alam; Roger McLendon; Jeffrey I Everitt; Christopher B Newgard; Laurent Verkoczy; Garnett Kelsoe; Barton F Haynes
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

8.  High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.

Authors:  Jonathan T Sullivan; Chidananda Sulli; Alberto Nilo; Anila Yasmeen; Gabriel Ozorowski; Rogier W Sanders; Andrew B Ward; P J Klasse; John P Moore; Benjamin J Doranz
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 9.  Structural Insights from HIV-Antibody Coevolution and Related Immunization Studies.

Authors:  Jeffrey O Zhou; Therese Ton; Julia W Morriss; Diep Nguyen; Daniela Fera
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-15       Impact factor: 2.205

10.  Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.

Authors:  Caroline Petitdemange; Sudhir Pai Kasturi; Pamela A Kozlowski; Rafiq Nabi; Clare F Quarnstrom; Pradeep Babu Jagadeesh Reddy; Cynthia A Derdeyn; Lori M Spicer; Parin Patel; Traci Legere; Yevgeniy O Kovalenkov; Celia C Labranche; François Villinger; Mark Tomai; John Vasilakos; Barton Haynes; C Yong Kang; James S Gibbs; Jonathan W Yewdell; Dan Barouch; Jens Wrammert; David Montefiori; Eric Hunter; Rama R Amara; David Masopust; Bali Pulendran
Journal:  JCI Insight       Date:  2019-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.